Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. (Record no. 27950284)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02605 a2200769 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517193550.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201909s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2040-2058 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.3851/IMP3218 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Peters, Lars |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190924 |
| 245 00 - TITLE STATEMENT | |
| Title | Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Antiviral therapy |
| Date of publication, distribution, etc. | 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 405-413 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adenine |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Retroviral Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiretroviral Therapy, Highly Active |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CD4 Lymphocyte Count |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Coinfection |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | DNA, Viral |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Viral |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Utilization |
| General subdivision | statistics & numerical data |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Europe |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Guanine |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B Surface Antigens |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B virus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B, Chronic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lamivudine |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Organophosphonates |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyethylene Glycols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Practice Guidelines as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tenofovir |
| General subdivision | therapeutic use |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mocroft, Amanda |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grint, Daniel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moreno, Santiago |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Calmy, Alexandra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jevtovic, Djordje |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sambatakou, Helen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lacombe, Karine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | De Wit, Stephane |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rockstroh, Jürgen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smidt, Jelena |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Karpov, Igor |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grzeszczuk, Anna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Haziosmanovic, Vesnadarjan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gottfredsson, Magnus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Radoi, Roxana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kuzovatova, Elena |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Orkin, Chloe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ridolfo, Anna Lisa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zapirain, Jose |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lundgren, Jens |
| 773 0# - HOST ITEM ENTRY | |
| Title | Antiviral therapy |
| Related parts | vol. 23 |
| -- | no. 5 |
| -- | p. 405-413 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.3851/IMP3218">https://doi.org/10.3851/IMP3218</a> |
| Public note | Available from publisher's website |
No items available.